Entera Bio Ltd.
ENTX
$2.06
-$0.16-7.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 42.00K | 82.00K | 42.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 42.00K | 82.00K | 42.00K |
| Cost of Revenue | -- | -- | 42.00K | 82.00K | 42.00K |
| Gross Profit | -- | -- | 0.00 | 0.00 | 0.00 |
| SG&A Expenses | 1.61M | 1.15M | 1.44M | 1.14M | 1.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.26M | 2.67M | 2.61M | 2.42M | 3.06M |
| Operating Income | -3.26M | -2.67M | -2.56M | -2.34M | -3.02M |
| Income Before Tax | -3.20M | -2.66M | -2.57M | -2.34M | -3.02M |
| Income Tax Expenses | -- | -- | -- | 14.00K | -- |
| Earnings from Continuing Operations | -3.20M | -2.66M | -2.57M | -2.36M | -3.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.20M | -2.66M | -2.57M | -2.36M | -3.02M |
| EBIT | -3.26M | -2.67M | -2.56M | -2.34M | -3.02M |
| EBITDA | -3.25M | -2.66M | -2.56M | -2.33M | -3.01M |
| EPS Basic | -0.07 | -0.06 | -0.06 | -0.06 | -0.08 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.04 | -0.04 | -0.05 |
| EPS Diluted | -0.07 | -0.06 | -0.06 | -0.06 | -0.08 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.04 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 47.09M | 46.84M | 43.38M | 39.11M | 37.64M |
| Average Diluted Shares Outstanding | 47.09M | 46.84M | 43.38M | 39.11M | 37.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |